Cargando…
Targeting transforming growth factor beta signaling in metastatic osteosarcoma
Osteosarcoma is a rare type of bone cancer, and half of the cases affect children and adolescents younger than 20 years of age. Despite intensive efforts to improve both chemotherapeutics and surgical management, the clinical outcome for metastatic osteosarcoma remains poor. Transforming growth fact...
Autores principales: | Ge, Rongrong, Huang, Gavin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666000/ https://www.ncbi.nlm.nih.gov/pubmed/38021074 http://dx.doi.org/10.1016/j.jbo.2023.100513 |
Ejemplares similares
-
Pro‐tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma
por: Portela, R.F., et al.
Publicado: (2014) -
Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?
por: Giampieri, S, et al.
Publicado: (2006) -
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
por: Roane, Brandon M., et al.
Publicado: (2019) -
Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
por: Papoutsoglou, Panagiotis, et al.
Publicado: (2019) -
Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration
por: Gilbert, Richard W.D., et al.
Publicado: (2016)